# Tempest Therapeutics, Inc.: Form 8-K, filed Nov 1, 2018

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: 8-K
- Filed: 2018-11-01
- Accepted by EDGAR: Nov 1, 2018, 17:01 ET
- Period: 2018-10-29
- Accession: 0001047469-18-006977
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000104746918006977/a2237038z8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000104746918006977/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.01: Delisting notice
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000104746918006977/a2237038z8-k.htm

Filed Nov 1, 2018.
Source: SEC EDGAR, the filing index for accession 0001047469-18-006977. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
